EACPT participation in HCPWP
The European Medicines Agency Healthcare Professionals’ Working Party or HCPWP provides recommendations to the European Medicines Agency and its scientific committees on all matters of interest to healthcare professionals in relation to medicinal products, and monitors the progress of interaction between the Agency and healthcare professionals. The HCPWP is composed of representatives from healthcare professionals’ organisations that fulfil the eligibility criteria as well as the Agency’s human scientific committees and the Agency secretariat.
Role of EACPT at the EMA-HCPWP
Eighteen learned societies are members of the HCPWP, together with representatives from all EMA Scientific Committees and EMA Staff. EACPT has a prominent role and representation at the HCPWP, including HCPWP co-chair by Gonzalo Calvo (EACPT President) and Isabelle Moulon (EMA representative). In addition, Tabassome Simon and Donald Singer are official representatives of EACPT in the EMA-HCPWP for a 3-year mandate (ending on November 2016).
EACPT is committed to disseminate HCPWP activities and proposal among their affiliates, proposed areas of interaction. The HCPWP works in close collaboration with the Patients and Consumers Working Party (EMA-PCWP). Associate EACPT members are invited to take an active voice in enhancing the contribution of EACPT to this Group.
EMA-HCPWP participated workshops
European Medicines Agency Human Scientific Committees’ Working Party with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals Working Party (HCPWP) joint meeting – Workshop on regulatory and methodological standards to improve benefit/risk evaluation of medicines
European Medicines Agency Human Scientific Committees’ Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting – Workshop on benefit-risk communication